Effect of Normatec Pump for Relief of Leg Edema
NCT01112150 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2010-04-28
Summary
The investigators hypothesize that leg edema will decrease rapidly when using the NormaTec pump, patients will lose weight, will feel better, will be less prone to infections in their legs and to congestion of the liver. Temporary elevation of intravascular fluid volume by the mobilized edema fluid returned to the intravascular space by pumping may increase cardiac output and renal perfusion and in addition it may distend the right atrium and ventricle thus inducing BNP secretion. Both mechanisms may promote excess fluid removal by the kidneys.
Conditions
- Edema
- Heart Failure
- Pulmonary Hypertension
Interventions
- DEVICE
-
NormaTec Pump
Normatec Pump
Sponsors & Collaborators
-
Hillel Yaffe Medical Center
lead OTHER_GOV
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2012-04-30
- Completion
- 2012-07-31
Countries
- Israel
Study Locations
More Related Trials
-
Optimization of Heart Failure (HF) Medical Therapy After Transcatheter Valve Intervention (TVI) in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)
NCT06667128 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Iron in Congestive Heart Failure
NCT01837082 ·Status: TERMINATED ·Phase: PHASE3
-
Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure
NCT06831825 ·Status: RECRUITING ·Phase: PHASE1
-
Permanent Pacing for Drug-refractory Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.
NCT05771987 ·Status: UNKNOWN ·Phase: NA
-
Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)
NCT01477528 ·Status: COMPLETED
-
A Feasibility Study on Ultrafiltration and Blood Volume Measurements
NCT04241718 ·Status: TERMINATED ·Phase: NA
-
Enhanced External Counterpulsation
NCT01355315 ·Status: COMPLETED
-
Identifying and Facilitating Ventricular Recovery on Mechanical Support
NCT00687856 ·Status: COMPLETED
-
Swedish Evaluation of Left Ventricular Assist Device as Permanent Treatment in End-stage Heart Failure
NCT02592499 ·Status: RECRUITING ·Phase: NA
-
Stimulation of the Diaphragm in Patients With Severe Heart Failure Following Heart Surgery
NCT00769678 ·Status: COMPLETED ·Phase: NA
-
PVP-Guided Decongestive Therapy in HF
NCT05217342 ·Status: UNKNOWN ·Phase: PHASE4
-
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
NCT01166347 ·Status: COMPLETED ·Phase: NA
-
Transcatheter Fontan Stenting: Impact on Hepatic Stiffness and Exercise Capacity
NCT07073612 ·Status: RECRUITING
-
Enhanced External Counter Pulsation on Afterload Mismatch Rate in Post-TEER (PAMPER)
NCT06227286 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Clinical Trial to Evaluate the HeartWare MVAD® System (MVAdvantage)
NCT01831544 ·Status: TERMINATED ·Phase: NA
-
University of Michigan Advanced Heart Failure Tele-Monitoring and Flexible Diuretic Project
NCT02344342 ·Status: TERMINATED ·Phase: NA
-
Beta-blocker Administration for Cardiomyocyte Division
NCT04713657 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
NCT01001312 ·Status: TERMINATED ·Phase: PHASE4
-
Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER)
NCT02339974 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Non-ischemic Cardiomyopathies by Intravenous Extracellular Vesicles of Cardiovascular Progenitor Cells
NCT05774509 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of the HeartWare Left Ventricular Assist Device for the Treatment of Advanced Heart Failure
NCT00751972 ·Status: COMPLETED ·Phase: NA
-
MOMENTUM 3 IDE Clinical Study Protocol
NCT02224755 ·Status: COMPLETED ·Phase: NA
-
Parasympathetic Augmentation Via Respiratory Training for Patients With Systolic Heart Failure
NCT05223751 ·Status: TERMINATED ·Phase: NA
-
HF Patients With LVADs Being Treated With SGLT2i
NCT05278962 ·Status: COMPLETED ·Phase: PHASE4
-
Carillon Mitral Contour System for Treatment of Exercise Induced Functional Mitral Regurgitation
NCT05040451 ·Status: WITHDRAWN